Request Deal Involvement

GHO Capital-backed RoslinCT to acquire Lykan Bioscience.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Consilium Strategic Communications

pr advisors

Consilium Strategic Communications

Ropes & Gray

legal advisors

Ropes & Gray

Alvarez & Marsal

tax advisors

Alvarez & Marsal

ERM Group

environmental advisors

ERM Group

Slaughter & May

legal advisors

Slaughter & May

Alvarez & Marsal

financial advisors

Alvarez & Marsal

Dark Horse Consulting Group

technical advisors

Dark Horse Consulting Group

McDermott Will & Emery

legal advisors

McDermott Will & Emery

William Blair & Co

financial advisors

William Blair & Co

or

Principals

GHO CAPITAL PARTNERS LLP

bidder

GHO CAPITAL PARTNERS LLP

LYKAN BIOSCIENCE

target

LYKAN BIOSCIENCE

ROSLINCT

bidder

ROSLINCT

WINDROSE HEALTH INVESTORS LLC

vendor

WINDROSE HEALTH INVESTORS LLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - GHO Capital-backed RoslinCT to acquire Lykan Bioscience.